8link48 Posted December 7, 2018 Posted December 7, 2018 I don't know whether or not I'm in the right topic, but I'd like to know why we can't try to create a mutation in natural killer cells to target cancer cells within the human body. If it is possible is there any chance you could describe the process?
StringJunky Posted December 7, 2018 Posted December 7, 2018 (edited) Cancer cells are normal cells with messed up DNA. Their surface signatures are likely the same as normal cells, so killer cells can't tell the difference. Edited December 7, 2018 by StringJunky
Hans de Vries Posted December 8, 2018 Posted December 8, 2018 We will be able to do that soon with most cancers. We already have CAR T in use https://www.cancer.gov/about-cancer/treatment/research/car-t-cells We also have drugs like Ipilimumab and Pembrolizumab that "force" the immune system to attack cancer cells. A combination of Ipilimumab and Nivolumab wuadrupled 5 year survival for metadtatic melanoma
ecoli Posted December 12, 2018 Posted December 12, 2018 On 12/8/2018 at 4:04 AM, Hans de Vries said: We will be able to do that soon with most cancers. We already have CAR T in use https://www.cancer.gov/about-cancer/treatment/research/car-t-cells We also have drugs like Ipilimumab and Pembrolizumab that "force" the immune system to attack cancer cells. A combination of Ipilimumab and Nivolumab wuadrupled 5 year survival for metadtatic melanoma This is off topic to the OP, since your cited approach is engineered adaptive immunity. NK cells are part of the innate immune system and are activated by cytokines or interferons = no antibodies involved.
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now